Total Valuation
Dongsung Pharmaceutical Co., Ltd. has a market cap or net worth of ₩141.14B. The enterprise value is $92.76K.
Market Cap₩141.14B
Enterprise Value$92.76K
Share Statistics
Dongsung Pharmaceutical Co., Ltd. has 96,619,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding96,619,510
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dongsung Pharmaceutical Co., Ltd.’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -19.94%.
Return on Equity (ROE)-1.10
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-19.94%
Return on Capital Employed (ROCE)-0.59
Revenue Per Employee283.94M
Profits Per Employee-83.83M
Employee Count307
Asset Turnover0.52
Inventory Turnover2.61
Valuation Ratios
The current PE Ratio of Dongsung Pharmaceutical Co., Ltd. is ―. Dongsung Pharmaceutical Co., Ltd.’s PEG ratio is -0.00340.
PE Ratio―
PS Ratio0.26
PB Ratio0.95
Price to Fair Value0.95
Price to FCF-1.57
Price to Operating Cash Flow-5.44
PEG Ratio-0.00340
Income Statement
In the last 12 months, Dongsung Pharmaceutical Co., Ltd. had revenue of 87.17B and earned -25.74B in profits. Earnings per share was -1.13K.
Revenue87.17B
Gross Profit36.36B
Operating Income-22.87B
Pretax Income-28.69B
Net Income-25.74B
EBITDA-20.73B
Earnings Per Share (EPS)-1.13K
Cash Flow
In the last 12 months, operating cash flow was -25.26B and capital expenditures -906.25M, giving a free cash flow of -26.16B billion.
Operating Cash Flow-25.26B
Free Cash Flow-26.16B
Free Cash Flow per Share-270.80
Dividends & Yields
Dongsung Pharmaceutical Co., Ltd. pays an annual dividend of $30, resulting in a dividend yield of ―
Dividend Per Share$30
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta<0.01
52-Week Price Change49.85%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Dongsung Pharmaceutical Co., Ltd. upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Dongsung Pharmaceutical Co., Ltd. as a current ratio of 0.69, with Debt / Equity ratio of 44.13%
Current Ratio0.69
Quick Ratio0.54
Debt to Market Cap2.88
Net Debt to EBITDA-2.91
Interest Coverage Ratio-2.35
Taxes
In the past 12 months, Dongsung Pharmaceutical Co., Ltd. has paid -2.95B in taxes.
Income Tax-2.95B
Effective Tax Rate0.10
Enterprise Valuation
Dongsung Pharmaceutical Co., Ltd. EV to EBITDA ratio is -3.98, with an EV/FCF ratio of -5.83.
EV to Sales0.95
EV to EBITDA-3.98
EV to Free Cash Flow-5.83
EV to Operating Cash Flow-6.42
Balance Sheet
Dongsung Pharmaceutical Co., Ltd. has ₩37.47B in cash and marketable securities with ₩38.61B in debt, giving a net cash position of -₩1.14B billion.
Cash & Marketable Securities₩37.47B
Total Debt₩38.61B
Net Cash-₩1.14B
Net Cash Per Share-₩11.75
Tangible Book Value Per Share₩1.00K
Margins
Gross margin is 41.24%, with operating margin of -26.23%, and net profit margin of -29.53%.
Gross Margin41.24%
Operating Margin-26.23%
Pretax Margin-32.91%
Net Profit Margin-29.53%
EBITDA Margin-23.78%
EBIT Margin-26.23%
Analyst Forecast
The average price target for Dongsung Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-9.11%
EPS Growth Forecast79.32%